| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.44 | $40.03 (0%) | 🛒 Add to cart |
| 120 | $0.37 | $53.38 $44.04 (17%) | 🛒 Add to cart |
| 180 | $0.30 | $80.07 $54.05 (32%) | 🛒 Add to cart |
| 360 | $0.22
Best per pill | $160.14 $79.07 (51%) | 🛒 Add to cart |
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.72 | $43.04 (0%) | 🛒 Add to cart |
| 90 | $0.54 | $64.56 $49.04 (24%) | 🛒 Add to cart |
| 120 | $0.46 | $86.08 $55.05 (36%) | 🛒 Add to cart |
| 180 | $0.38 | $129.11 $68.06 (47%) | 🛒 Add to cart |
| 270 | $0.32 | $193.67 $86.08 (56%) | 🛒 Add to cart |
| 360 | $0.29
Best per pill | $258.23 $104.09 (60%) | 🛒 Add to cart |
| Product dosage: 750mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.97 | $59.05 (0%) | 🛒 Add to cart |
| 60 | $1.38 | $118.10 $83.07 (30%) | 🛒 Add to cart |
| 90 | $1.18 | $177.15 $106.09 (40%) | 🛒 Add to cart |
| 120 | $1.08 | $236.21 $130.11 (45%) | 🛒 Add to cart |
| 180 | $0.98 | $354.31 $177.15 (50%) | 🛒 Add to cart |
| 360 | $0.88
Best per pill | $708.62 $317.28 (55%) | 🛒 Add to cart |
Synonyms | |||
Similar products
More info:
Cipro: Potent Antibacterial Therapy for Bacterial Infections - Evidence-Based Review
Ciprofloxacin, commonly known by its brand name Cipro, is a broad-spectrum fluoroquinolone antibiotic with potent bactericidal activity against a wide range of Gram-positive and Gram-negative pathogens. Its development in the 1980s represented a significant advancement in antimicrobial therapy, offering an oral alternative to intravenous antibiotics for serious infections. In clinical practice, ciprofloxacin has become a cornerstone for treating complicated urinary tract infections, bacterial prostatitis, certain types of infectious diarrhea, and respiratory infections in patients with cystic fibrosis, among other indications.
Ciprodex Ophthalmic Solution: Effective Management of Ocular Inflammation and Infection - Evidence-Based Review
Ciprodex Ophthalmic Solution represents a significant advancement in treating complex ocular surface infections, combining the broad-spectrum antibacterial coverage of ciprofloxacin with the potent anti-inflammatory action of dexamethasone. This fixed-dose combination addresses both the infectious component and the inflammatory response that often complicates recovery in conditions like bacterial conjunctivitis and post-surgical prophylaxis. 1. Introduction: What is Ciprodex Ophthalmic Solution? Its Role in Modern Ophthalmology Ciprodex Ophthalmic Solution represents a sophisticated therapeutic approach in ocular medicine, specifically formulated to address the dual challenges of bacterial infection and concurrent inflammation.
Besivance Ophthalmic Solution: Effective Bacterial Conjunctivitis Treatment - Evidence-Based Review
Besivance ophthalmic solution is a sterile, topical antibiotic formulation specifically designed for treating bacterial infections of the eye. It contains besifloxacin, a fluoroquinolone antimicrobial, in a concentration of 0.6% (6 mg/mL). This solution is preserved with sodium chloride, edetate disodium, and sodium hydroxide or hydrochloric acid to adjust pH, all suspended in a proprietary vehicle. Its primary role in modern ophthalmology is to provide a potent, broad-spectrum option for tackling bacterial conjunctivitis, offering a convenient dosing regimen that supports patient adherence.
Ciloxan Ophthalmic Solution: Effective Bacterial Conjunctivitis Treatment - Evidence-Based Review
Ciloxan ophthalmic solution is a sterile, preservative-free topical antibiotic formulation specifically designed for ocular infections. It contains ciprofloxacin hydrochloride, a broad-spectrum fluoroquinolone, at a concentration equivalent to 0.3% ciprofloxacin. The solution is isotonic and buffered to maintain a pH compatible with the tear film, minimizing irritation upon instillation. It’s packaged in a unique, single-use vial system that prevents contamination and ensures sterility throughout the treatment course. We initially developed this formulation after observing unacceptably high contamination rates in multi-dose antibiotic bottles on our ophthalmology ward – a problem that disappeared completely after switching to unit-dose packaging.
Ciplox: Potent Broad-Spectrum Antibacterial Therapy - Evidence-Based Review
Ciprofloxacin, commonly encountered in clinical practice as Ciplox, represents a cornerstone fluoroquinolone antibiotic with a broad spectrum of activity against Gram-positive and Gram-negative bacteria. Its development marked a significant advancement in antimicrobial therapy, particularly for complex infections where older agents failed. We initially saw its potential during the early 90s surge in resistant Pseudomonas and Enterobacteriaceae cases, but its role has since been refined with greater understanding of its safety profile.
clozaril
Clozaril, known generically as clozapine, represents one of the most significant advances in psychopharmacology for treatment-resistant schizophrenia. It’s not your typical antipsychotic—this is a second-generation atypical antipsychotic medication reserved for cases where multiple other treatments have failed. What makes Clozaril so distinctive isn’t just its mechanism but the rigorous monitoring protocol that accompanies its use, creating a unique risk-benefit profile that demands careful clinical consideration. ## 1. Introduction: What is Clozaril?
esbriet
Pirfenidone, marketed as Esbriet, represents one of the few approved antifibrotic agents specifically indicated for idiopathic pulmonary fibrosis. This small molecule pyridone derivative works through complex anti-inflammatory and antifibrotic pathways that we’re still unraveling. When I first encountered Esbriet in clinical trials back in 2010, the pulmonary community was desperate for anything that could modify the relentless progression of IPF. We’d been watching patients decline on prednisone and azathioprine regimens that often did more harm than good.
flagyl er
Flagyl ER (extended-release metronidazole) represents a significant pharmaceutical advancement in the treatment of anaerobic and protozoal infections. This 750 mg once-daily formulation maintains therapeutic plasma concentrations for 24 hours, addressing key compliance challenges seen with the conventional 250-500 mg TID dosing. We’ve moved beyond simply treating trichomoniasis or amebiasis—this delivery system fundamentally changes how we manage chronic anaerobic infections like bacterial vaginosis recurrence and Crohn’s disease complications. The extended-release matrix uses a hydrophilic polymer system that swells upon gastric fluid contact, creating a gel layer that controls metronidazole diffusion.
Floxin: Potent Broad-Spectrum Antibiotic for Resistant Infections - Evidence-Based Review
Ofoxacin, commonly known by its brand name Floxin, represents a significant advancement in the fluoroquinolone class of antibiotics. This synthetic broad-spectrum antimicrobial agent has been a workhorse in clinical practice for decades, particularly valuable for its activity against both gram-positive and gram-negative bacteria, including some atypical pathogens. Its development marked a shift toward more potent oral agents that could effectively treat serious infections outside hospital settings. I remember when it first hit our hospital formulary back in the early 90s – we were suddenly able to discharge complicated UTI patients on oral therapy who would’ve previously required weeks of IV antibiotics.